NCT03324685View on ClinicalTrials.gov

A Drug Interaction Study of BIIB074 and an Oral Contraceptive Regimen

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 11, 2017

Primary Completion Date

March 15, 2018

Study Completion Date

March 15, 2018

Conditions
Drug Interactions
Interventions
DRUG

BIIB074

BIIB074 is administered as specified in the treatment arm.

DRUG

OC (ethinyl estradiol and levonorgestrel)

OC is administered as specified in the treatment arm.

Trial Locations (1)

32117

Research Site, Daytona Beach

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY

NCT03324685 - A Drug Interaction Study of BIIB074 and an Oral Contraceptive Regimen | Biotech Hunter | Biotech Hunter